Advanced in Pancreatic Cancer

Nicolas Williet

Saint-etienne-de-valoux, FR 
Advanced in Pancreatic Cancer
Saint-etienne-de-valoux, FR 
OverviewLocationsClinical Research

Overview

Nicolas Williet practices in Saint-etienne-de-valoux, France. Mr. Williet is rated as an Advanced expert by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Viral Gastroenteritis, Colitis, Pancreatic Cancer, Liver Embolization, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 85 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 21 articles in the study of Pancreatic Cancer.

Gender
Male

Locations

Saint-etienne-de-valoux, France
Other Locations
Avenue Albert Raimond, Saint-priest-la-vetre, 42270, France
France
CHU Amiens Picardie
Amiens, France
Bordeaux, France
Lyon, France
Vandoeuvre-les-nancy, France
University Hospital Of St Etienne, LINA EA 4624, Saint-jean-saint-germain, France
Paris, 75908, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents
MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug
Study Phase: Not Applicable
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment After the Failure of the Cisplatin (or Carboplatin)-Etoposide Combination in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer. A Phase 2 Non-comparative Randomized Study
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment After the Failure of the Cisplatin (or Carboplatin)-Etoposide Combination in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer. A Phase 2 Non-comparative Randomized Study
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Drugs: Folfiri+Bevacizumab, Folfiri
Study Phase: Phase 2
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up
Enrollment Status: Terminated
Publish Date: June 05, 2025
Intervention Type: Biological, Procedure
Study Drug: Blood sample
Study Phase: Not Applicable
Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions -
Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions -
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Procedure
iDEFCO: Implementation of a Tool to Identify Social Weaknesses in the Cancer Care Pathway
iDEFCO: Implementation of a Tool to Identify Social Weaknesses in the Cancer Care Pathway
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Other
Pharmacokinetic and Pharmacodynamic Study of Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Pharmacokinetic and Pharmacodynamic Study of Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Enrollment Status: Completed
Publish Date: March 14, 2022
Intervention Type: Drug, Diagnostic test, Biological
Study Drug: Golimumab
Study Phase: Phase 2
Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis: A Protocol of a Multi-center Prospective Randomized Investigator Blinded Trial.
Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis: A Protocol of a Multi-center Prospective Randomized Investigator Blinded Trial.
Enrollment Status: Completed
Publish Date: August 26, 2021
Intervention Type: Drug
Study Drugs: 5-ASA, Corticosteroids
Study Phase: Phase 3
View 6 Less Clinical Trials

85 Total Publications

Medical management of pancreatic cancer: from personalization to broadening treatment strategies.
Medical management of pancreatic cancer: from personalization to broadening treatment strategies.
Journal: Cancer treatment reviews
Published: May 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Williet's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile